Hydroxychloroquine, double-blind studies, convalescent plasma, herd immunity — the coronavirus pandemic has thrust the language of science into public view as never before.
But familiarity with the terminology does not necessarily lead to a better understanding, especially when there is an avalanche of new findings, experts caution. When researchers disagree or change their mind on the efficacy of a treatment or policy, the normal back-and-forth of the scientific process can breed confusion, they say.
Read the full story here.
